Bausch Health Cos Return on Investment 2010-2023 | BHC
Current and historical return on investment (ROI) values for Bausch Health Cos (BHC) over the last 10 years.
| Bausch Health Cos ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2023-12-31 |
$0.96B |
$21.86B |
4.57% |
| 2023-09-30 |
$0.37B |
$21.66B |
1.78% |
| 2023-06-30 |
$0.60B |
$20.38B |
2.91% |
| 2023-03-31 |
$0.35B |
$20.35B |
1.66% |
| 2022-12-31 |
$0.45B |
$20.59B |
2.09% |
| 2022-09-30 |
$1.07B |
$21.24B |
4.80% |
| 2022-06-30 |
$1.40B |
$21.92B |
6.21% |
| 2022-03-31 |
$0.96B |
$23.03B |
4.25% |
| 2021-12-31 |
$0.45B |
$22.62B |
1.97% |
| 2021-09-30 |
$0.08B |
$22.22B |
0.33% |
| 2021-06-30 |
$-0.04B |
$22.83B |
-0.15% |
| 2021-03-31 |
$0.21B |
$23.61B |
0.84% |
| 2020-12-31 |
$0.68B |
$24.53B |
3.63% |
| 2020-09-30 |
$-0.40B |
$25.00B |
-2.09% |
| 2020-06-30 |
$-0.53B |
$24.90B |
-2.74% |
| 2020-03-31 |
$-0.24B |
|
-1.23% |
| 2019-12-31 |
$-0.20B |
$25.80B |
-0.77% |
| 2019-09-30 |
$0.90B |
$26.03B |
3.38% |
| 2019-06-30 |
$0.69B |
$26.71B |
2.54% |
| 2019-03-31 |
$0.18B |
$26.70B |
0.67% |
| 2018-12-31 |
$-2.38B |
$26.89B |
-8.46% |
| 2018-09-30 |
$-2.73B |
$27.67B |
-9.33% |
| 2018-06-30 |
$-2.81B |
$28.42B |
-9.29% |
| 2018-03-31 |
$-2.39B |
$29.79B |
-7.69% |
| 2017-12-31 |
$0.10B |
$31.18B |
0.32% |
| 2017-09-30 |
$0.57B |
$31.64B |
1.79% |
| 2017-06-30 |
$-0.33B |
$31.68B |
-0.99% |
| 2017-03-31 |
$-0.42B |
$32.19B |
-1.24% |
| 2016-12-31 |
$-0.57B |
$33.10B |
-1.61% |
| 2016-09-30 |
$-0.55B |
$34.66B |
-1.52% |
| 2016-06-30 |
$0.76B |
$36.18B |
2.08% |
| 2016-03-31 |
$1.02B |
$37.08B |
2.79% |
| 2015-12-31 |
$1.53B |
$36.29B |
4.30% |
| 2015-09-30 |
$1.97B |
$36.64B |
6.21% |
| 2015-06-30 |
$2.20B |
$36.85B |
7.95% |
| 2015-03-31 |
$2.22B |
$32.47B |
9.20% |
| 2014-12-31 |
$2.00B |
$20.63B |
9.28% |
| 2014-09-30 |
$1.62B |
$20.82B |
7.36% |
| 2014-06-30 |
$0.04B |
$22.43B |
0.20% |
| 2014-03-31 |
$-0.17B |
$22.35B |
-0.82% |
| 2013-12-31 |
$-0.41B |
$22.40B |
-2.20% |
| 2013-09-30 |
$-0.73B |
$22.11B |
-4.41% |
| 2013-06-30 |
$0.19B |
$16.15B |
1.36% |
| 2013-03-31 |
$0.14B |
$13.91B |
1.07% |
| 2012-12-31 |
$0.08B |
$14.25B |
0.67% |
| 2012-09-30 |
$0.17B |
$11.21B |
1.57% |
| 2012-06-30 |
$0.25B |
$11.05B |
2.44% |
| 2012-03-31 |
$0.29B |
$10.93B |
2.86% |
| 2011-12-31 |
$0.30B |
$10.47B |
3.12% |
| 2011-09-30 |
$0.26B |
$9.20B |
2.83% |
| 2011-06-30 |
$0.02B |
$9.20B |
0.20% |
| 2011-03-31 |
$-0.05B |
$9.41B |
-0.73% |
| 2010-12-31 |
$-0.11B |
$8.39B |
-2.18% |
| 2010-09-30 |
$-0.00B |
$8.46B |
-0.06% |
| 2010-06-30 |
$0.18B |
$1.66B |
14.58% |
| 2010-03-31 |
$0.14B |
$1.66B |
17.30% |
| 2009-12-31 |
$0.18B |
$1.67B |
43.65% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.143B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
